New Zealand markets closed

G1 Therapeutics, Inc. (GTHX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
5.17+0.23 (+4.66%)
At close: 04:00PM EDT
5.61 +0.44 (+8.51%)
After hours: 07:50PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
24,160
31,476
45,285
0
0
Cost of revenue
2,442
2,016
-
-
-
Gross profit
21,718
29,460
-
-
-
Operating expenses
Research development
85,990
76,225
73,271
89,002
70,683
Selling general and administrative
99,431
95,692
68,490
40,039
18,603
Total operating expenses
185,421
171,917
141,761
129,041
89,286
Operating income or loss
-163,703
-142,457
-96,476
-129,041
-89,286
Interest expense
6,184
4,667
1,778
-
-
Total other income/expenses net
-461
-346
-542
6,594
3,998
Income before tax
-170,315
-147,427
-97,844
-122,447
-85,288
Income tax expense
787
925
1,410
-
-
Income from continuing operations
-171,102
-148,352
-99,254
-122,447
-85,288
Net income
-171,102
-148,352
-99,254
-122,447
-85,288
Net income available to common shareholders
-171,102
-148,352
-99,254
-122,447
-85,288
Basic EPS
-
-3.54
-2.62
-3.27
-2.56
Diluted EPS
-
-3.54
-2.62
-3.27
-2.56
Basic average shares
-
41,943
37,878
37,499
33,317
Diluted average shares
-
41,943
37,878
37,499
33,317
EBITDA
-
-142,291
-95,484
-128,685
-89,111